Medicon Hellas Statistics

Total Valuation

Medicon Hellas has a market cap or net worth of EUR 9.94 million. The enterprise value is 11.46 million.

Market Cap	9.94M
Enterprise Value	11.46M

Important Dates

The next estimated earnings date is Tuesday, April 29, 2025.

Earnings Date	Apr 29, 2025
Ex-Dividend Date	Jul 15, 2024

Share Statistics

Medicon Hellas has 4.42 million shares outstanding.

Current Share Class	n/a
Shares Outstanding	4.42M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	n/a
Owned by Institutions (%)	0.41%
Float	n/a

Valuation Ratios

The trailing PE ratio is 11.81.

PE Ratio	11.81
Forward PE	n/a
PS Ratio	0.55
PB Ratio	0.57
P/TBV Ratio	0.57
P/FCF Ratio	14.81
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 3.95, with an EV/FCF ratio of 17.07.

EV / Earnings	13.97
EV / Sales	0.64
EV / EBITDA	3.95
EV / EBIT	9.79
EV / FCF	17.07

Financial Position

The company has a current ratio of 4.81, with a Debt / Equity ratio of 0.56.

Current Ratio	4.81
Quick Ratio	3.94
Debt / Equity	0.56
Debt / EBITDA	3.46
Debt / FCF	14.93
Interest Coverage	1.89

Financial Efficiency

Return on equity (ROE) is 5.17% and return on invested capital (ROIC) is 2.58%.

Return on Equity (ROE)	5.17%
Return on Assets (ROA)	2.27%
Return on Invested Capital (ROIC)	2.58%
Return on Capital Employed (ROCE)	4.27%
Revenue Per Employee	104,593
Profits Per Employee	4,772
Employee Count	174
Asset Turnover	0.56
Inventory Turnover	1.69

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -29.25% in the last 52 weeks. The beta is 0.71, so Medicon Hellas's price volatility has been lower than the market average.

Beta (5Y)	0.71
52-Week Price Change	-29.25%
50-Day Moving Average	2.25
200-Day Moving Average	2.44
Relative Strength Index (RSI)	45.66
Average Volume (20 Days)	1,647

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Medicon Hellas had revenue of EUR 17.99 million and earned 820,811 in profits. Earnings per share was 0.19.

Revenue	17.99M
Gross Profit	12.79M
Operating Income	1.17M
Pretax Income	876,536
Net Income	820,811
EBITDA	2.49M
EBIT	1.17M
Earnings Per Share (EPS)	0.19

Full Income Statement

Balance Sheet

The company has 9.02 million in cash and 10.03 million in debt, giving a net cash position of -1.01 million or -0.23 per share.

Cash & Cash Equivalents	9.02M
Total Debt	10.03M
Net Cash	-1.01M
Net Cash Per Share	-0.23
Equity (Book Value)	17.97M
Book Value Per Share	3.95
Working Capital	17.58M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 2.04 million and capital expenditures -1.37 million, giving a free cash flow of 671,463.

Operating Cash Flow	2.04M
Capital Expenditures	-1.37M
Free Cash Flow	671,463
FCF Per Share	0.15

Full Cash Flow Statement

Margins

Gross margin is 71.09%, with operating and profit margins of 6.51% and 4.56%.

Gross Margin	71.09%
Operating Margin	6.51%
Pretax Margin	4.87%
Profit Margin	4.56%
EBITDA Margin	13.82%
EBIT Margin	6.51%
FCF Margin	3.73%

Dividends & Yields

This stock pays an annual dividend of 0.06, which amounts to a dividend yield of 2.67%.

Dividend Per Share	0.06
Dividend Yield	2.67%
Dividend Growth (YoY)	-60.82%
Years of Dividend Growth	n/a
Payout Ratio	74.80%
Buyback Yield	n/a
Shareholder Yield	2.67%
Earnings Yield	8.25%
FCF Yield	6.75%

Dividend Details

Stock Splits

The last stock split was on July 28, 2004. It was a forward split with a ratio of 1.1.

Last Split Date	Jul 28, 2004
Split Type	Forward
Split Ratio	1.1

Scores

Medicon Hellas has an Altman Z-Score of 2.41. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.41
Piotroski F-Score	n/a